At RainGene, you’ll accelerate your career development through creating and commercializing innovative POCT products that will improve the quality of lives worldwide.
Molecular Analysis on Point Of Care Testing (POCT) is designed to quickly detect and identify pathogens with the aid of advanced CRISPR/Cas technology.
Dr. Jing-Wei Xiong is Professor, College of Future Technology at Peking University, who is well-known for his discoveries on cardiac regenerative small molecules and very first CRISPR–induced zebrafish and rat mutant technology in China.